137 related articles for article (PubMed ID: 9805306)
1. Use of transvaginal ultrasonography to monitor the effects of tamoxifen on uterine leiomyoma size and ovarian cyst formation.
Schwartz LB; Rutkowski N; Horan C; Nachtigall LE; Snyder J; Goldstein SR
J Ultrasound Med; 1998 Nov; 17(11):699-703. PubMed ID: 9805306
[TBL] [Abstract][Full Text] [Related]
2. Tamoxifen and ovarian cysts: a prospective study.
Seoud M; El-saghir N; Salem Z; Shamseddine A; Awwad J; Medawar W; Khalil A
Eur J Obstet Gynecol Reprod Biol; 2001 Dec; 100(1):77-80. PubMed ID: 11728662
[TBL] [Abstract][Full Text] [Related]
3. Cystic degeneration of a uterine leiomyoma masquerading as a postmenopausal ovarian cyst. A case report.
Yarwood RL; Arroyo E
J Reprod Med; 1999 Jul; 44(7):649-52. PubMed ID: 10442334
[TBL] [Abstract][Full Text] [Related]
4. Simple ovarian cysts in postmenopausal patients with breast carcinoma treated with tamoxifen: long-term follow-up.
Cohen I; Potlog-Nahari C; Shapira J; Yigael D; Tepper R
Radiology; 2003 Jun; 227(3):844-8. PubMed ID: 12728183
[TBL] [Abstract][Full Text] [Related]
5. Ovarian cysts in women receiving tamoxifen for breast cancer.
Mourits MJ; de Vries EG; Willemse PH; ten Hoor KA; Hollema H; Sluiter WJ; de Bruijn HW; van der Zee AG
Br J Cancer; 1999 Apr; 79(11-12):1761-4. PubMed ID: 10206289
[TBL] [Abstract][Full Text] [Related]
6. Ovarian cysts in premenopausal and postmenopausal tamoxifen-treated women with breast cancer.
Shushan A; Peretz T; Uziely B; Lewin A; Mor-Yosef S
Am J Obstet Gynecol; 1996 Jan; 174(1 Pt 1):141-4. PubMed ID: 8571997
[TBL] [Abstract][Full Text] [Related]
7. Mitotically active leiomyoma of the uterus in a postmenopausal breast cancer patient receiving tamoxifen.
Liu IF; Yen YS; Cheng YM; Chou CY
Taiwan J Obstet Gynecol; 2006 Jun; 45(2):167-9. PubMed ID: 17197361
[TBL] [Abstract][Full Text] [Related]
8. Effects of raloxifene treatment on uterine leiomyomas in postmenopausal women.
Palomba S; Sammartino A; Di Carlo C; Affinito P; Zullo F; Nappi C
Fertil Steril; 2001 Jul; 76(1):38-43. PubMed ID: 11438317
[TBL] [Abstract][Full Text] [Related]
9. Ovarian cysts in postmenopausal tamoxifen-treated breast cancer patients with endometrial thickening detected by transvaginal sonography.
Kazandi M; Sendag F; Akercan F; Terek MC; Ozsaran A; Dikmen Y
Eur J Gynaecol Oncol; 2002; 23(3):257-60. PubMed ID: 12094966
[TBL] [Abstract][Full Text] [Related]
10. The role of 99mTc-bound phosphates and grey scale echography in the differentiation of pelvic tumors.
Manfredi OL; Aruny JE
Clin Nucl Med; 1979 Mar; 4(3):99-107. PubMed ID: 428170
[TBL] [Abstract][Full Text] [Related]
11. Co-occurrence of atypical endometriosis, subserous uterine leiomyomata, sactosalpinx, serous cystadenoma and bilateral hemorrhagic corpora lutea in a perimenopausal adipose patient taking tamoxifen (20 mg/day) for invasive lobular breast cancer.
Ebert AD; Rosenow G; David M; Mechsner S; Magalov IS; Papadopoulos T
Gynecol Obstet Invest; 2008; 66(3):209-13. PubMed ID: 18645252
[TBL] [Abstract][Full Text] [Related]
12. Torsion of a functional ovarian cyst in a premenopausal patient receiving tamoxifen.
Nasu K; Miyazaki T; Kiyonaga Y; Kawasaki F; Miyakawa I
Gynecol Obstet Invest; 1999; 48(3):200-2. PubMed ID: 10545747
[TBL] [Abstract][Full Text] [Related]
13. The role of tamoxifen in the treatment of symptomatic uterine leiomyomata -- a pilot study.
Sadan O; Ginath S; Sofer D; Rotmensch S; Debby A; Glezerman M; Zakut H
Eur J Obstet Gynecol Reprod Biol; 2001 Jun; 96(2):183-6. PubMed ID: 11384804
[TBL] [Abstract][Full Text] [Related]
14. Rapid growth of leiomyoma in patient receiving tamoxifen.
Dilts PV; Hopkins MP; Chang AE; Cody RL
Am J Obstet Gynecol; 1992 Jan; 166(1 Pt 1):167-8. PubMed ID: 1733191
[TBL] [Abstract][Full Text] [Related]
15. Transvaginal ultrasound examination of the endometrium in postmenopausal women without vaginal bleeding.
Jokubkiene L; Sladkevicius P; Valentin L
Ultrasound Obstet Gynecol; 2016 Sep; 48(3):390-6. PubMed ID: 26678251
[TBL] [Abstract][Full Text] [Related]
16. [The effects of tamoxifen on the female genital tract].
Mourits MJ; van der Zee AG; Willemse PH; Hollema H; de Vries EG
Ned Tijdschr Geneeskd; 2003 Nov; 147(47):2315-20. PubMed ID: 14669536
[TBL] [Abstract][Full Text] [Related]
17. Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas.
Magalhães J; Aldrighi JM; de Lima GR
Contraception; 2007 Mar; 75(3):193-8. PubMed ID: 17303488
[TBL] [Abstract][Full Text] [Related]
18. Transvaginal US and hysterosonography in postmenopausal women with breast cancer receiving tamoxifen: correlation with hysteroscopy and pathologic study.
Fong K; Causer P; Atri M; Lytwyn A; Kung R
Radiographics; 2003; 23(1):137-50; discussion 151-5. PubMed ID: 12533649
[TBL] [Abstract][Full Text] [Related]
19. The effects of norethisterone on endometrial abnormalities identified by transvaginal ultrasound screening of healthy post-menopausal women on tamoxifen or placebo.
Powles TJ; Bourne T; Athanasiou S; Chang J; Gruböck K; Ashley S; Oakes L; Tidy A; Davey J; Viggers J; Humphries S; Collins W
Br J Cancer; 1998 Jul; 78(2):272-5. PubMed ID: 9683306
[TBL] [Abstract][Full Text] [Related]
20. Uterine leiomyosarcoma in a postmenopausal woman treated with tamoxifen: case report.
Sabatini R; Di Fazio F; Loizzi P
Eur J Gynaecol Oncol; 1999; 20(4):327-8. PubMed ID: 10475136
[No Abstract] [Full Text] [Related]
[Next] [New Search]
